statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024 Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a...

Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024

Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society...

Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference

Trevi Therapeutics to Participate in Upcoming April Events Trevi Therapeutics to Participate in Upcoming April Events PR Newswire NEW HAVEN, Conn., April 4, 2024 NEW HAVEN, Conn., April 4, 2024...

Trevi Therapeutics to Participate in Upcoming April Events

Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team PR Newswire NEW...

Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team

Over the last three days, A.I.dvisor has detected that TRVI's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

Trevi Therapeutics (TRVI, $3.37) Aroon Indicator entered an Uptrend on April 01, 2024.

Trevi Therapeutics (TRVI, $3.46) Aroon Indicator entered an Uptrend on March 28, 2024.

This is a Bearish indicator signaling TRVI's price could decline from here. Traders may explore shorting the stock or put options...

Trevi Therapeutics (TRVI, $3.4) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 26, 2024

Trevi Therapeutics (TRVI, $3.4) Aroon Indicator entered an Uptrend on March 26, 2024.

This is a signal that TRVI's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Trevi Therapeutics (TRVI, $3.35) RSI Indicator left the overbought zone on March 25, 2024

Trevi Therapeutics (TRVI, $3.35) Aroon Indicator entered an Uptrend on March 25, 2024.

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson’s disease. The company was founded by Thomas R. Sciascia and Jennifer L. Good in March 2011 and is headquartered in New Haven, CT.

Volume	26,782.00
52-Wk High	$4.00
52-Wk Low	$0.97

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.09	--	--	N/A
Q4'23	-$0.09	-$0.08	12.73%	BEAT
Q3'23	-$0.09	-$0.08	12.73%	BEAT
Q2'23	-$0.09	-$0.07	17.65%	BEAT
Q1'23	-$0.07	-$0.06	18.85%	BEAT

TRVI Trevi Therapeutics Inc

About

Feed

News

Earnings

Fundamentals